| Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma I Janoueix-Lerosey, D Lequin, L Brugières, A Ribeiro, L De Pontual, ... Nature 455 (7215), 967-970, 2008 | 1034 | 2008 |
| Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data V Boeva, T Popova, K Bleakley, P Chiche, J Cappo, G Schleiermacher, ... Bioinformatics 28 (3), 423-425, 2012 | 914 | 2012 |
| Advances in risk classification and treatment strategies for neuroblastoma NR Pinto, MA Applebaum, SL Volchenboum, KK Matthay, WB London, ... Journal of clinical oncology 33 (27), 3008, 2015 | 804 | 2015 |
| Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations TF Eleveld, DA Oldridge, V Bernard, J Koster, LC Daage, SJ Diskin, ... Nature genetics 47 (8), 864-871, 2015 | 537 | 2015 |
| International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee PF Ambros, IM Ambros, GM Brodeur, M Haber, J Khan, A Nakagawara, ... British journal of cancer 100 (9), 1471-1482, 2009 | 448 | 2009 |
| Germline mutations of the paired–like homeobox 2B (PHOX2B) gene in neuroblastoma D Trochet, F Bourdeaut, I Janoueix-Lerosey, A Deville, L De Pontual, ... The American Journal of Human Genetics 74 (4), 761-764, 2004 | 415 | 2004 |
| Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries V Boeva, C Louis-Brennetot, A Peltier, S Durand, C Pierre-Eugène, ... Nature genetics 49 (9), 1408-1413, 2017 | 403 | 2017 |
| Overall genomic pattern is a predictor of outcome in neuroblastoma I Janoueix-Lerosey, G Schleiermacher, E Michels, V Mosseri, A Ribeiro, ... Journal of clinical oncology 27 (7), 1026-1033, 2009 | 365 | 2009 |
| Revisions to the international neuroblastoma response criteria: a consensus statement from the National Cancer Institute clinical trials planning meeting JR Park, R Bagatell, SL Cohn, AD Pearson, JG Villablanca, F Berthold, ... Journal of Clinical Oncology 35 (22), 2580, 2017 | 249 | 2017 |
| Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network GG Malouf, P Camparo, S Oudard, G Schleiermacher, C Theodore, ... Annals of Oncology 21 (9), 1834-1838, 2010 | 249 | 2010 |
| Increased risk of systemic relapses associated with bone marrow micrometastasis and circulating tumor cells in localized Ewing tumor G Schleiermacher, M Peter, O Oberlin, T Philip, H Rubie, F Mechinaud, ... Journal of Clinical Oncology 21 (1), 85-91, 2003 | 236 | 2003 |
| Emergence of New ALK Mutations at Relapse of Neuroblastoma G Schleiermacher, N Javanmardi, V Bernard, Q Leroy, J Cappo, ... Journal of Clinical Oncology 32 (25), 2727-2734, 2014 | 223 | 2014 |
| Accumulation of segmental alterations determines progression in neuroblastoma G Schleiermacher, I Janoueix-Lerosey, A Ribeiro, J Klijanienko, ... Journal of Clinical Oncology 28 (19), 3122-3130, 2010 | 195 | 2010 |
| Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study J Vermeulen, K De Preter, A Naranjo, L Vercruysse, N Van Roy, ... The lancet oncology 10 (7), 663-671, 2009 | 193 | 2009 |
| Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project G Schleiermacher, V Mosseri, WB London, JM Maris, GM Brodeur, ... British journal of cancer 107 (8), 1418-1422, 2012 | 188 | 2012 |
| Two distinct deleted regions on the short arm of chromosome I in neuroblastoma G Schleiermacher, M Peter, J Michon, JP Hugot, P Vielh, JM Zucker, ... Genes, Chromosomes and Cancer 10 (4), 275-281, 1994 | 186 | 1994 |
| An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours P Mestdagh, E Fredlund, F Pattyn, A Rihani, T Van Maerken, J Vermeulen, ... Oncogene 29 (24), 3583-3592, 2010 | 178 | 2010 |
| Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumours DTW Jones, A Banito, TGP Grünewald, M Haber, N Jäger, M Kool, T Milde, ... Nature Reviews Cancer 19 (8), 420-438, 2019 | 151 | 2019 |
| Prognostic impact of gene expression–based classification for neuroblastoma A Oberthuer, B Hero, F Berthold, D Juraeva, A Faldum, Y Kahlert, ... Journal of Clinical Oncology 28 (21), 3506-3515, 2010 | 142 | 2010 |
| Whole-exome sequencing of cell-free DNA reveals temporo-spatial heterogeneity and identifies treatment-resistant clones in neuroblastoma M Chicard, L Colmet-Daage, N Clement, A Danzon, M Bohec, V Bernard, ... Clinical Cancer Research 24 (4), 939-949, 2018 | 136 | 2018 |
